A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples